Slideshow
Author(s):
This month’s roundup covers hip fracture risk, improvements in diabetes-associated risk assessment, and a model to calculate gestational diabetes risk.
New studies on diabetes show current use of glucose-lowering drugs is associated with hip fracture in patients with type 2 mellitus (T2DM); standard methods of assessing bone health may underestimate the amount of risk fracture in diabetes patients; and a new tool can identify obese women who are at high risk of developing gestational DM early in pregnancy.